Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 37% | 8.2% | 15.1% |
| Success rate | 53% | 68% | 82% |
| Transactions |
4
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Independent Director | Beyond Air Inc | Aug. 13, 2018 - |
| President - Medical, Research and Development and Chief Development Officer | Salix Pharmaceuticals Ltd | Feb. 2, 2015 - April 1, 2015 |
| Executive Vice President - Research and Development, Chief Medical Officer, Chief Development Officer | Salix Pharmaceuticals Ltd | Jan. 1, 2010 - Feb. 2, 2015 |
Search